News Focus
News Focus
Followers 65
Posts 27745
Boards Moderated 0
Alias Born 11/23/2016

Re: baltimorebullet post# 121319

Friday, 09/22/2017 10:29:31 AM

Friday, September 22, 2017 10:29:31 AM

Post# of 517486
One of the present efforts in that direction is the CAR-T approach applicable across several types of cancer. I believe Missling is making that comparison with the approach Anavex is pursuing for CNS diseases.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News